HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ki Won Lee Selected Research

3,3',4,5'-tetrahydroxystilbene

5/2022Piceatannol, a metabolite of resveratrol, attenuates atopic dermatitis by targeting Janus kinase 1.
2/2021Piceatannol Is Superior to Resveratrol at Suppressing Adipogenesis in Human Visceral Adipose-Derived Stem Cells.
11/2015Inhibition of tumor progression by oral piceatannol in mouse 4T1 mammary cancer is associated with decreased angiogenesis and macrophage infiltration.
10/2013Piceatannol suppresses the metastatic potential of MCF10A human breast epithelial cells harboring mutated H-ras by inhibiting MMP-2 expression.
8/2013Piceatannol enhances cisplatin sensitivity in ovarian cancer via modulation of p53, X-linked inhibitor of apoptosis protein (XIAP), and mitochondrial fission.
3/2012Piceatannol, natural polyphenolic stilbene, inhibits adipogenesis via modulation of mitotic clonal expansion and insulin receptor-dependent insulin signaling in early phase of differentiation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ki Won Lee Research Topics

Disease

105Neoplasms (Cancer)
12/2023 - 06/2002
33Carcinogenesis
12/2023 - 01/2002
29Inflammation (Inflammations)
11/2022 - 10/2005
23Obesity
02/2024 - 08/2011
16Skin Neoplasms (Skin Cancer)
03/2016 - 07/2008
15Colonic Neoplasms (Colon Cancer)
10/2017 - 01/2005
14Neoplasm Metastasis (Metastasis)
08/2022 - 01/2007
11Neurodegenerative Diseases (Neurodegenerative Disease)
05/2017 - 01/2006
11Prostatic Neoplasms (Prostate Cancer)
06/2016 - 05/2011
10Alzheimer Disease (Alzheimer's Disease)
05/2023 - 01/2007
10Melanoma (Melanoma, Malignant)
10/2017 - 06/2007
10Neoplastic Cell Transformation
05/2016 - 09/2007
9Atopic Dermatitis (Atopic Eczema)
05/2022 - 01/2013
9Atherosclerosis
02/2018 - 01/2006
7Insulin Resistance
01/2021 - 05/2013
6Pheochromocytoma
06/2011 - 04/2008
5Cardiovascular Diseases (Cardiovascular Disease)
02/2018 - 09/2004
5Hypoxia (Hypoxemia)
05/2017 - 05/2010
5Hypertension (High Blood Pressure)
06/2016 - 10/2005
5Breast Neoplasms (Breast Cancer)
06/2016 - 01/2007
4Metabolic Diseases (Metabolic Disease)
12/2023 - 10/2013
4Type 2 Diabetes Mellitus (MODY)
06/2022 - 02/2012
4Dermatitis
05/2022 - 07/2009
4Psoriasis (Pustulosis Palmaris et Plantaris)
01/2018 - 10/2010
4Osteoarthritis
10/2017 - 12/2015
4Carcinoma (Carcinomatosis)
06/2016 - 08/2011
4Adenocarcinoma
01/2016 - 01/2004
4Body Weight (Weight, Body)
11/2015 - 12/2012
4Edema (Dropsy)
06/2014 - 02/2013
3Pain (Aches)
05/2023 - 03/2016
3Lymphoma (Lymphomas)
05/2023 - 12/2003
3Fatigue
12/2022 - 12/2015
3Hyperpigmentation
06/2022 - 02/2015
3Memory Disorders (Memory Loss)
01/2020 - 02/2016
3Lung Neoplasms (Lung Cancer)
10/2017 - 12/2014
3Chronic Disease (Chronic Diseases)
07/2017 - 01/2013
3Leukemia
07/2015 - 05/2006

Drug/Important Bio-Agent (IBA)

22PhytochemicalsIBA
02/2023 - 01/2004
21Proteins (Proteins, Gene)FDA Link
12/2023 - 10/2008
21AntioxidantsIBA
09/2022 - 01/2004
16Cyclooxygenase 2 (Cyclooxygenase-2)IBA
06/2013 - 12/2004
15CytokinesIBA
12/2022 - 07/2009
14Phosphotransferases (Kinase)IBA
12/2023 - 07/2008
11LipidsIBA
05/2019 - 12/2003
10Reactive Oxygen Species (Oxygen Radicals)IBA
05/2017 - 01/2006
10Matrix Metalloproteinases (MMPs)IBA
10/2016 - 01/2006
9ResveratrolIBA
05/2022 - 11/2007
8Glucose (Dextrose)FDA LinkGeneric
01/2021 - 05/2013
8IsoflavonesIBA
02/2020 - 11/2007
8PolyphenolsIBA
05/2019 - 01/2005
7Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
04/2012 - 01/2004
63,3',4,5'-tetrahydroxystilbeneIBA
05/2022 - 03/2012
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2017 - 04/2010
6Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
05/2015 - 09/2007
6FlavonoidsIBA
12/2013 - 10/2005
6myricetinIBA
07/2011 - 09/2007
5sulforaphaneIBA
12/2023 - 07/2014
5InterleukinsIBA
12/2022 - 08/2011
5EnzymesIBA
04/2022 - 08/2011
5NF-kappa B (NF-kB)IBA
06/2017 - 12/2004
5QuercetinIBA
05/2014 - 03/2005
4sulphorapheneIBA
02/2024 - 01/2016
4Phosphoric Monoester Hydrolases (Phosphatases)IBA
12/2023 - 07/2012
4Caspase 3 (Caspase-3)IBA
05/2023 - 12/2003
4orobolIBA
01/2023 - 01/2019
4Protein Kinases (Protein Kinase)IBA
01/2023 - 06/2007
4Cisplatin (Platino)FDA LinkGeneric
03/2020 - 08/2013
4Messenger RNA (mRNA)IBA
07/2017 - 01/2013
4Cyclin D1IBA
05/2017 - 08/2011
4daidzeinIBA
05/2017 - 11/2007
4Ethanol (Ethyl Alcohol)IBA
01/2017 - 01/2005
4Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
05/2016 - 04/2009
4Epidermal Growth Factor (EGF)IBA
03/2016 - 07/2010
4Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
09/2015 - 08/2010
4kaempferolIBA
02/2014 - 08/2010
4LuteolinIBA
10/2013 - 03/2010
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2011 - 04/2009
4Ascorbic Acid (Vitamin C)FDA LinkGeneric
02/2008 - 01/2002
3Neuroprotective AgentsIBA
05/2023 - 07/2014
3Interleukin-6 (Interleukin 6)IBA
12/2022 - 01/2018
3Chlorogenic AcidIBA
05/2022 - 06/2011
3GinsenosidesIBA
05/2022 - 01/2014
3Insulin (Novolin)FDA Link
01/2021 - 03/2016
3GenisteinIBA
09/2020 - 04/2011
33',4',7-trihydroxyisoflavoneIBA
02/2020 - 04/2011
3Amyloid (Amyloid Fibrils)IBA
01/2020 - 05/2017
3Biomarkers (Surrogate Marker)IBA
02/2018 - 12/2015
3indole-3-carbinolIBA
10/2017 - 12/2012
3LeptinIBA
12/2016 - 08/2011
3isoangustone AIBA
06/2016 - 10/2013
3Glycyrrhizic Acid (Glycyrrhizin)IBA
06/2016 - 12/2013
3DNA (Deoxyribonucleic Acid)IBA
01/2016 - 01/2005
3Transcription Factors (Transcription Factor)IBA
11/2015 - 12/2004
3Cyclin AIBA
11/2015 - 08/2011
3ErbB Receptors (EGF Receptor)IBA
12/2014 - 07/2010
3Peptides (Polypeptides)IBA
03/2014 - 12/2003

Therapy/Procedure

12Therapeutics
12/2023 - 10/2008
10Chemoprevention
01/2014 - 12/2003
4Drug Therapy (Chemotherapy)
01/2018 - 10/2008
3Oral Administration
11/2015 - 10/2013